FDA Brief

Warning letters Drugs

FDA warning letter to

MYM Hidrominerales S.A. de C.V.

High riskIssued Apr 9, 2021Posted Apr 13, 2021Center for Drug Evaluation and Research

MYM Hidrominerales' Protz hand sanitizer labeled 70% ethanol was found to contain 79% methanol instead.

What happened

An attempted import of Protz real protection Antibacterial Hand Sanitizer, labeled as manufactured at MYM Hidrominerales' facility, was detained and refused admission at the U.S. border. FDA laboratory testing found the product averaged 0.05% ethanol and 79% methanol v/v, although the label stated 70% ethanol.

What FDA found

  1. The product was labeled to contain 70% ethanol but testing found about 0.05% ethanol and 79% methanol, so ethanol was substituted with methanol.

    FD&C Act section 501(d)(2), 21 U.S.C. 351(d)(2)
  2. The methanol substitution shows that quality assurance at the facility was not working under CGMP requirements.

    FD&C Act section 501(a)(2)(B), 21 U.S.C. 351(a)(2)(B)
  3. The hand sanitizer is an unapproved new drug sold without FDA approval.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  4. The product is dangerous to health when used as labeled because it contains methanol.

    FD&C Act section 502(j), 21 U.S.C. 352(j)
  5. The label falsely states 70% ethanol and does not disclose the methanol in the product.

    FD&C Act sections 502(a) and 502(e)(1)(A), 21 U.S.C. 352(a), 352(e)(1)(A)
  6. The label lacks the required swallow warning and a complete domestic address or phone number for serious adverse event reports.

    FD&C Act sections 502(f)(2) and 502(x), 21 U.S.C. 352(f)(2), 352(x)

What FDA wants

FDA asks the company to respond in writing within 15 working days with an investigation into how ethanol was substituted with methanol, lists of raw materials and suppliers, batch and distribution information for U.S. shipments, and complete batch records. If the company cannot meet that deadline, it must state why and give a completion schedule; FDA also strongly recommends a qualified CGMP consultant if the firm intends to resume making drugs for the U.S. market.

Who should pay attention

  • brands or distributors that sell hand sanitizer made by this firm
  • retailers and importers sourcing Mexican hand sanitizer
  • consumers and healthcare buyers relying on the label's ethanol content

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. World Perfumes Inc.

    World Perfumes failed to test drug ingredients for toxic contaminants and had inadequate water, FDA says.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Kabana Skin Care LLC

    Kabana Skin Care failed to test OTC drug ingredients and finished products, prompting a recall and halt of U.S. drug manufacturing.

    High risk
  4. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk